Collegium Pharmaceutical Inc - Company Profile
Powered by 
All the sales intelligence you need on Collegium Pharmaceutical Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Collegium Pharmaceutical Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Collegium Pharmaceutical Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that develops and commercializes next generation extended-release, abuse-deterrent products for the treatment of chronic pain and acute pain. Market position, lead product Xtampza ER, and DETERx technology platform are its strengths even as customer concentration could be a major cause for concern for the company. The company could benefit from market opportunity of jornay PM, increased growth potential for pain medications, and strategic agreement. However, high competition, dependence on third party suppliers, and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer